Erlotinib mesylate
Erlotinib is a reversible inhibitor that targets the epidermal growth factor receptor (EGFR) by competitively binding to its ATP-binding site. It is widely used in cancer research, particularly in studies of non-small cell lung cancer and pancreatic cancer, for both in vitro cellular assays and in vivo xenograft models.
Product Specifications
CAS Number
248594-19-6
Field of Research
Cardiovascular Research, Cell Biology, Pharmacology & Drug Discovery, Signal Transduction
Smiles
O=S (=O) (O) C.C#CC1=CC=CC (=C1) NC=2N=CN=C3C=C (OCCOC) C (OCCOC) =CC32
Molecular Formula
C23H27N3O7S
Molecular Weight
489.54
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7062417 Inquire
Recombinant Escherichia coli O157:H7 Lipid A biosynthesis lauroyl acyltransferase (htrB), partial
Sign In for Pricing
View Details 